Facts & figures
As of: January, 2019
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992, incl. BIMSB
2) primarily from own ressources, since 2001
3) primarily from own ressources
4) since 2009
5) since 2006
6) since 2002
| Research Institutions of Campus Berlin-Buch Employees (total) |
2,151 |
|
| of these: | ||
| Max Delbrück Center for Molecular Medicine (MDC): | 1,646 | |
| Leibniz Institute of Molecular Pharmacology (FMP): | 303 | |
| Klinische Forschung Charité Campus Buch: | 202 | |
| Budget and third-party grants (total)1 | EUR 192 million | |
| Max Delbrück Center for Molecular Medicine (MDC): | EUR 147 million | |
| Leibniz Institute of Molecular Pharmacology (FMP): | EUR 29 million | |
| Klinische Forschung Charité Campus Buch: | EUR 16 million | |
| BiotechPark Berlin-Buch | ||
| Number of companies: | 62 | |
| Employees: | 800 | |
| Annual revenue: Percentage of third-party grants: 3,1% |
EUR 220 million |
|
| Hospitals & Patient-Care Institutions | ||
| Employees (total): of these: |
3,564 | |
| HELIOS Klinikum Berlin-Buch: | 2,700 | |
| Evangelische Lungenklinik: | 325 | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik): | 89 |
|
| Patient-care institutions: | 450 | |
| Number of patient beds: | 1,267 | |
| Patients per year (inpatient and outpatient): | 220,519 | |
| Total investment volume of these: |
EUR 1.451 billion | |
| Infrastructure Campus Berlin-Buch1 | EUR 624 million | |
| HELIOS Klinikum Berlin-Buch² | EUR 336 million | |
| Evangelische Lungenklinik3 | EUR 49 million | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1 | EUR 39 million |
|
| LudwigPark 3 | EUR 45 million | |
| Allées des Châteaux 3 | EUR 23 million | |
| Widerker Vermögensverwaltung (Schlosspark-Passage) 3 | EUR 29 million |
|
| Ludwig Hoffmann Quartier | EUR 152 million |
|
| Housing construction associations (HOWOGE 3,4, EWG 3,5, WBG 3,6 Hau+S 3,5 ) | EUR 154 million |
News Buch Berlin
Biosynth Expands Berlin Site with a New Commercial Bioconjugation Suite
The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply.
more ...The cellular engineer
Molecular machines carry out many vital processes inside our cells. When their components – protein building blocks – are faulty, it can lead to disease. Structural biologist Oliver Daumke investigate...
more ...Cutting the environmental impact of research
From reducing freezer usage to plastic waste, Max Delbrück Center labs have been implementing strategies from the LEAF program for sustainable research. As more labs join the program, they are not onl...
more ...Events Buch Berlin
20.07.2025, 11:00
Führung „Wildnis am Stadtrand – Freie Pferde als Landschaftspfleger“
Kostenfreie Führung mit Antonia Gerke zum Thema „Pferde als Landschaftspfleger“
more ...20.07.2025, 17:00
„Wildnis am Stadtrand“
Eine informative Tour über das natürliche Verhalten von frei lebenden Pferden als Landschaftspfleger und das Verhalten von Wölfen mit Pferdefachfrau Antonia Gerke & als Gast Autor, Jäger und Wolfsexpe...
more ...
